MUC1 and neoplasm: Indeed, in preclinical models of pancreatic and prostate cancer, CAR T cells directed against mucin-1 (MUC1) and prostate stem cell antigen (PSCA) were unable to eradicate solid tumors, and tumor escape was attributed to tumor cells expressing low densities of target antigen [44].